Phase II study of amrubicin and carboplatin in patients with the refractory or relapsed small cell lung cancer (SCLC).

被引：2
|
作者：
Hirose, T. [1 ]
Shirai, T. [1 ]
Kusumoto, S. [1 ]
Sugiyama, T. [1 ]
Yamaoka, T. [1 ]
Okuda, K. [1 ]
Ohmori, T. [1 ]
Ohnishi, T. [1 ]
Adachi, M. [1 ]
机构：
[1] Showa Univ, Sch Med, Tokyo 142, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7057
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PHASE II STUDY OF AMRUBICIN IN PATIENTS WITH REFRACTORY OR RESISTANT RELAPSED SMALL-CELL LUNG CANCER: JAPAN CLINICAL ONCOLOGY GROUP STUDY (JCOG0901)
    Daga, H.
    Murakami, H.
    Yamamoto, N.
    Shibata, T.
    Endo, M.
    Watanabe, H.
    Ichinose, Y.
    Yamamoto, N.
    Ohe, Y.
    Tamura, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 492 - 492
  • [42] Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer
    Pietanza, Maria Catherine
    Pereira, Leanne
    Dunne, Meghan
    Travis, William D.
    Chan, Timothy A.
    Ginsberg, Michelle S.
    Holodny, Andrei
    Kris, Mark G.
    Krug, Lee M.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S819 - S820
  • [43] Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer
    Pietanza, M. Catherine
    Travis, William D.
    Chan, Timothy A.
    Ginsberg, Michelle S.
    Kris, Andrei Holodny Mark G.
    Krug, Lee M.
    PANCREAS, 2010, 39 (02) : 279 - 279
  • [44] A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC).
    Owonikoko, Taofeek Kunle
    Higgins, Kristin Ann
    Chen, Zhengjia
    Zhang, Chao
    Pillai, Rathi Narayana
    Steuer, Conor Ernst
    Saba, Nabil F.
    Pakkala, Suchita
    Shin, Dong Moon
    Zhang, Guojing
    Wang, Shuhua
    Hossain, Mohammed S.
    Beardslee, Tyler
    Engelhart, Anne
    Revenig, Janine
    Khuri, Fadlo
    Curran, Walter John, Jr.
    Lonial, Sagar
    Waller, Edmund K.
    Ramalingam, Suresh S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402
    Nogami, Naoyuki
    Hotta, Katsuyuki
    Segawa, Yoshihiko
    Takigawa, Nagio
    Hosokawa, Shinobu
    Oze, Isao
    Fujii, Masanori
    Ichihara, Eiki
    Shibayama, Takuo
    Tada, Atsuhiko
    Hamada, Noboru
    Uno, Masatoshi
    Tamaoki, Akihiko
    Kuyama, Shoichi
    Ikeda, Genyo
    Osawa, Masahiro
    Takata, Saburo
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    ACTA ONCOLOGICA, 2012, 51 (06) : 768 - 773
  • [46] Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic oncology research group study 0301
    Onoda, Sayaka
    Masuda, Noriyuki
    Seto, Takashi
    Eguchi, Kenji
    Takiguchi, Yuichi
    Isobe, Hiroshi
    Okamoto, Hiroaki
    Ogura, Takashi
    Yokoyama, Akira
    Seki, Nobuhiko
    Asaka-Amano, Yoshiko
    Harada, Masao
    Tagawa, Akihiro
    Kunikane, Hiroshi
    Yokoba, Masanori
    Uematsu, Kazutsugu
    Kuriyama, Takayuki
    Kuroiwa, Yumi
    Watanabe, Koshiro
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) : 5448 - 5453
  • [47] A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC)
    Laack, Eckart
    Thoem, Ina
    Kruell, Andreas
    Engel-Riedel, Walburga
    Mueller, Thomas
    Meissner, Christoph
    Duerk, Heinz
    Fischer, Juergen
    Guetz, Sylvia
    Kortsik, Cornelius
    Elbers, Matthias
    Schuch, Gunter
    Andritzkya, Birte
    Goern, Michael
    Burkholder, Iris
    Edler, Lutz
    Hossfeld, Dieter Kurt
    Bokemeyer, Carsten
    LUNG CANCER, 2007, 57 (02) : 181 - 186
  • [48] Phase II study of carboplatin and irinotecan (CPT-11) in patients with limited disease small cell lung cancer (SCLC)
    Laack, E.
    Boeters, I.
    Kruell, A.
    Engel-Riedel, W.
    Mueller, T.
    Meibner, R.
    Duerk, H.
    Burkholder, I.
    Hossfeld, D. K.
    Bokemeyer, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 328 - 328
  • [49] DOCETAXEL-CARBOPLATIN (DC) AS SECOND LINE TREATMENT IN PATIENTS WITH SMALL CELL LUNG CANCER (SCLC): A PHASE II STUDY
    Van Riel, Sunit
    Schramel, Franz M. N. H.
    Smit, Hans J. M.
    Van Walree, Nico C.
    Groen, Harry J. M.
    Schreurs, Ad J. M.
    Biesma, Bonne
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1231 - S1231
  • [50] Randomized, phase II trial comparing amrubicin with topotecan in patients (pts) with previously treated small cell lung cancer (SCLC)
    Sugawara, S.
    Inoue, A.
    Yamazaki, K.
    Saijo, Y.
    Gomi, K.
    Ishimoto, O.
    Hommura, F.
    Maemondo, M.
    Suzuki, T.
    Nukiwa, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345